HI is diagnosed by demonstration of increased insulin secretion and actions during hypoglycemia, including detectable insulin, low free fatty acids (FFAs) and beta-hydroxybutyrate (BOHB), and a glycemic response to glucagon administration during hypoglycemia (1). Here, INS is linked to Hypoglycemia.